Genetic Inactivation of Sclerostin in a Mouse Model of Osteogenesis Imperfecta

被引：0
|
作者：
Boraschi-Diaz, Iris [1 ]
Tauer, Josephine T. [1 ]
Rauch, Frank [1 ]
机构：
[1] Shriners Hosp Children Canada, Montreal, PQ, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-858
引用
收藏
页码：366 / 366
页数：1
相关论文
共 50 条
  • [1] Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta
    Juliana Marulanda
    Josephine T. Tauer
    Iris Boraschi-Diaz
    Ghalib Bardai
    Frank Rauch
    Scientific Reports, 13
  • [2] Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta
    Marulanda, Juliana
    Tauer, Josephine T. T.
    Boraschi-Diaz, Iris
    Bardai, Ghalib
    Rauch, Frank
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta
    Roschger, Andreas
    Roschger, Paul
    Keplingter, Petra
    Klaushofer, Klaus
    Abdullah, Sami
    Kneissel, Michaela
    Rauch, Frank
    BONE, 2014, 66 : 182 - 188
  • [4] Sclerostin Antibody Improves Skeletal Parameters in a Brtl/+ Mouse Model of Osteogenesis Imperfecta
    Sinder, Benjamin P.
    Eddy, Mary M.
    Ominsky, Michael S.
    Caird, Michelle S.
    Marini, Joan C.
    Kozloff, Kenneth M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (01) : 73 - 80
  • [5] Sclerostin antibody-induced peri-implant osseointegration in Osteogenesis Imperfecta mouse model
    Sung, Hsiao
    Kwon, Hannah
    Ahmad, Azhan
    Stephan, Chris
    Blaney, Esmeralda
    Caird, Davidson Michelle
    Kozloff, Kenneth
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 353 - 353
  • [6] Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
    Cardinal, Mickael
    Chretien, Antoine
    Roels, Thomas
    Lafont, Sebastien
    Ominsky, Michael S.
    Devogelaer, Jean-Pierre
    Manicourt, Daniel H.
    Behets, Catherine
    FRONTIERS IN GENETICS, 2021, 12
  • [7] CIRCULATING SCLEROSTIN IN CHILDREN AND ADOLESCENTS WITH OSTEOGENESIS IMPERFECTA
    Al Agha, A.
    Qari, M.
    Ardawi, J.
    Ardawi, M. -S.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S458 - S458
  • [8] Metabolic phenotype in the mouse model of osteogenesis imperfecta
    Boraschi-Diaz, Iris
    Tauer, Josephine T.
    El-Rifai, Omar
    Guillemette, Delphine
    Lefebvre, Genevieve
    Rauch, Frank
    Ferron, Mathieu
    Komarova, Svetlana V.
    JOURNAL OF ENDOCRINOLOGY, 2017, 234 (03) : 279 - 289
  • [9] Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta
    Little, David G.
    Peacock, Lauren
    Mikulec, Kathy
    Kneissel, Michaela
    Kramer, Ina
    Cheng, Tegan L.
    Schindeler, Aaron
    Munns, Craig
    BONE, 2017, 101 : 96 - 103
  • [10] Fecundity is impaired in a mouse model of osteogenesis imperfecta
    Oestreich, Arin K.
    DeCata, Jenna A.
    Akers, Janae D.
    Phillips, Charlotte L.
    Schulz, Laura. C.
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2020, 87 (09) : 927 - 929
12345